Abbvie 430
Brief description of study
We are requesting a reliance agreement with an external IRB, Advarra.
The purpose of this study is to evaluate the safety of upadacitinib and as well PK of upadacitinib as maintenance treatment in subjects with moderate to severe CD who have responded to upadacitinib induction treatment in Study M14-431.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: - 99 Years
-
Gender: All
TBD
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
